| Serial Number | 79335933 |
| Word Mark | FEXUCLUE |
| Filing Date | Wednesday, January 19, 2022 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, August 1, 2023 |
| Registration Number | 7123404 |
| Registration Date | Tuesday, August 1, 2023 |
| Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, May 16, 2023 |
| Description of Mark | The mark consists of the stylized wording "FEXUCLUE" in blue, wherein the inside of the letter "C" is a design of the stomach in the colors red, orange, yellow and green. The color white in the mark is background only and is not claimed as a feature of the mark. |
| Goods and Services | Pharmaceutical agents affecting digestive organs; medicines for treating intestinal disorders; Pharmaceutical preparations in the nature of proton-pump inhibitors for the treatment of gastroesophageal reflux disease, peptic ulcer, intestinal disorders, gastrointestinal disorders, erosive esophagitis, gastritis, gastric ulcer, duodenal ulcer, non-erosive reflux disease, duodenal ulcer recurrence and pathological hypersecretory conditions including Zollinger-Ellison syndrome and combination antibiotic therapy for the treatment of Helicobacter pylori infection; medicines for the treatment of gastrointestinal diseases; medicines for human purposes for the treatment of gastroesophageal reflux disease, peptic ulcer, intestinal disorders, gastrointestinal disorders, erosive esophagitis, gastritis, gastric ulcer, duodenal ulcer, non-erosive reflux disease, duodenal ulcer recurrence and pathological hypersecretory conditions including Zollinger-Ellison syndrome and combination antibiotic therapy for the treatment of Helicobacter pylori infection; pharmaceutical preparations for the treatment of gastroesophageal reflux disease, peptic ulcer, intestinal disorders, gastrointestinal disorders, erosive esophagitis, gastritis, gastric ulcer, duodenal ulcer, non-erosive reflux disease, duodenal ulcer recurrence and pathological hypersecretory conditions including Zollinger-Ellison syndrome and combination antibiotic therapy for the treatment of Helicobacter pylori infection; ethical medicinal preparations for the treatment of gastroesophageal reflux disease, peptic ulcer, intestinal disorders, gastrointestinal disorders, erosive esophagitis, gastritis, gastric ulcer, duodenal ulcer, non-erosive reflux disease, duodenal ulcer recurrence and pathological hypersecretory conditions including Zollinger-Ellison syndrome and combination antibiotic therapy for the treatment of Helicobacter pylori infection |
| Indication of Colors claimed | The color(s) the colors blue, green, red, orange, and yellow are claimed as features of the mark is/are claimed as a feature of the mark. |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, March 18, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | DAEWOONG PHARMACEUTICAL CO., LTD. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | KR |
| Party Name | DAEWOONG PHARMACEUTICAL CO., LTD. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | KR |
| Party Name | DAEWOONG PHARMACEUTICAL CO., LTD. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | KR |
| Event Date | Event Description |
| Monday, November 27, 2023 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Friday, November 10, 2023 | NEW REPRESENTATIVE AT IB RECEIVED |
| Thursday, November 2, 2023 | FINAL DISPOSITION NOTICE SENT TO IB |
| Wednesday, November 1, 2023 | FINAL DISPOSITION PROCESSED |
| Wednesday, November 1, 2023 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Tuesday, August 1, 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Tuesday, August 1, 2023 | REGISTERED-PRINCIPAL REGISTER |
| Wednesday, May 17, 2023 | NOTIFICATION PROCESSED BY IB |
| Tuesday, May 16, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, May 16, 2023 | PUBLISHED FOR OPPOSITION |
| Wednesday, April 26, 2023 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Wednesday, April 26, 2023 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Wednesday, April 26, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Thursday, April 13, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Monday, March 20, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, March 17, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, March 17, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, February 1, 2023 | REFUSAL PROCESSED BY IB |
| Thursday, January 12, 2023 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Thursday, January 12, 2023 | REFUSAL PROCESSED BY MPU |
| Wednesday, November 2, 2022 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Tuesday, November 1, 2022 | NON-FINAL ACTION WRITTEN |
| Friday, October 28, 2022 | ASSIGNED TO EXAMINER |
| Tuesday, March 22, 2022 | APPLICATION FILING RECEIPT MAILED |
| Friday, March 18, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, March 17, 2022 | SN ASSIGNED FOR SECT 66A APPL FROM IB |